Zhonghai Shengrong Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 30, 2022	Fanzhi Medicine	$15.7M Series C	—	GoldenSand Capital
Sep 28, 2017	Royole Corporation	$800.0M Debt / Series D	—	Agricultural Bank of China, Bank of China, China CITIC Bank, Hanfor Capital, Industrial and Commercial Bank of China, Ping An, SPD Bank, TanShi Capital, Warmsun Holding Group

Total Raised

N/A

Valuation

N/A